RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 A Paradigm Shift in Early Drug Development: Individualizing to More Patient Benefit
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 15
SP 6
OP 7
DO 10.1177/155989771215002
UL http://mdc.sagepub.com/content/12/15/6.abstract
AB With the increasing the use of biomarkers in cancer treatment, the emphasis on selecting the right treatment for the right patient takes on added significance in early drug development. This article discusses the difficulties inherent in selecting patients for early drug-development studies.